Bronchial Associated Lymphoid Tissue Lymphoma in Systemic Lupus Erythematosus Successfully Treated with Rituximab
نویسندگان
چکیده
Bronchial Associated Lymphoid Tissue Lymphoma in Systemic Lupus Erythematosus Successfully Treated with Rituximab Eid AlQurashi1,2, Shikha Mittoo3, Zahi Touma4, Shane Shapera5, Theodore K Marras5,6 and Muhammad Sohail Anjum7* 1Department of Medicine, Division of Respirology, King Abdullah Medical City, Saudi Arabia 2Department of Medicine, Division of Respirology, University of Toronto, Toronto General Hospital, Canada 3Division of Rheumatology, Department of Medicine,University of Toronto, Mount Sinai Hospital, Canada 4Division of Rheumatology, Department of Medicine, University of Toronto, Toronto Western Hospital, Canada 5Department of Medicine, Division of Respirology, University of Toronto, Toronto General Hospital, Canada 6Division of Respirology, Universty of Toronto, Toronto Western Hospital, Medicine, Canada 7Department of Medicine, King Abdullah Medical City, Saudi Arabia
منابع مشابه
Controversies on Rituximab Therapy in Sjögren Syndrome-Associated Lymphoproliferation
Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by chronic inflammation of salivary and lachrymal glands, and frequently accompanied by systemic symptoms. A subgroup of SS patients develops malignant B cell non-Hodgkin's lymphoma (NHL), usually of the mucosa-associated lymphoid tissue (MALT) type and very often located in the major salivary glands. Currently, there is a l...
متن کاملOccult pulmonary mucosa-associated lymphoid tissue lymphoma presenting as catastrophic antiphospholipid antibody syndrome
Catastrophic antiphospholipid antibody syndrome (CAPS) is characterized by fulminant thrombosis of the arterial and venous beds of multiple organ systems over a relatively short period of time and with a high mortality rate. Mucosa-associated lymphoid tissue (MALT) lymphoma of the lung has never been reported as a causative or precipitating factor for CAPS in the CAPS registry database. The pre...
متن کاملAngiosarcoma of the Skin After Breast Cancer Radiotherapy
3. Thatayatikom A, White AJ. Rituximab: A promising therapy in systemic lupus erythematosus. Autoimmun Rev. 2006;5:18--24. 4. Boye J, Elter T, Engert A. An overview of the current clinical use of the anti-CD20 monoclonal antibody rituximab. Ann Oncol. 2003;14:520--35. 5. Cohen SB. Targeting the B cell in rheumatoid arthritis. Best Pract Res Clin Rheumatol. 2010;24:553--63. 6. Fatourechi MM, el-...
متن کاملPulmonary BALT Lymphoma Successfully Treated with Eight Cycles Weekly Rituximab: Report of First Case and F-18 FDG PET/CT Images
Extra marginal-zone lymphomas of the lung is a very rare tumor and it originates from bronchial-associated lymphoid tissue. A 68-yr-old woman presented with productive cough and dyspnea. A thorax computed tomography scan showed a 9 × 10 cm in size mass in the left lung and pleural effusion in the lower lobe of left lung. Positron emission tomography/computed tomography (PET/CT) revealed intense...
متن کاملRobust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab.
Rituximab is a therapeutic anti-CD20 monoclonal antibody widely used to treat B cell lymphoma and autoimmune diseases, such as rheumatic arthritis, systemic lupus erythematosus, and autoimmune blistering skin diseases (AIBD). While rituximab fully depletes peripheral blood B cells, it remains unclear whether some preexisting B cell memory to pathogens or vaccines may survive depletion, especial...
متن کامل